PMID- 24525332 OWN - NLM STAT- MEDLINE DCOM- 20141216 LR - 20220318 IS - 1096-7184 (Electronic) IS - 1096-7176 (Linking) VI - 23 DP - 2014 May TI - Metabolic engineering of a Saccharomyces cerevisiae strain capable of simultaneously utilizing glucose and galactose to produce enantiopure (2R,3R)-butanediol. PG - 92-9 LID - S1096-7176(14)00009-3 [pii] LID - 10.1016/j.ymben.2014.02.003 [doi] AB - 2,3-Butanediol (BDO) is an important chemical with broad industrial applications and can be naturally produced by many bacteria at high levels. However, the pathogenicity of these native producers is a major obstacle for large scale production. Here we report the engineering of an industrially friendly host, Saccharomyces cerevisiae, to produce BDO at high titer and yield. By inactivation of pyruvate decarboxylases (PDCs) followed by overexpression of MTH1 and adaptive evolution, the resultant yeast grew on glucose as the sole carbon source with ethanol production completely eliminated. Moreover, the pdc- strain consumed glucose and galactose simultaneously, which to our knowledge is unprecedented in S. cerevisiae strains. Subsequent introduction of a BDO biosynthetic pathway consisting of the cytosolic acetolactate synthase (cytoILV2), Bacillus subtilis acetolactate decarboxylase (BsAlsD), and the endogenous butanediol dehydrogenase (BDH1) resulted in the production of enantiopure (2R,3R)-butanediol (R-BDO). In shake flask fermentation, a yield over 70% of the theoretical value was achieved. Using fed-batch fermentation, more than 100g/L R-BDO (1100mM) was synthesized from a mixture of glucose and galactose, two major carbohydrate components in red algae. The high titer and yield of the enantiopure R-BDO produced as well as the ability to co-ferment glucose and galactose make our engineered yeast strain a superior host for cost-effective production of bio-based BDO from renewable resources. CI - Copyright (c) 2014 International Metabolic Engineering Society. Published by Elsevier Inc. All rights reserved. FAU - Lian, Jiazhang AU - Lian J AD - Department of Chemical and Biomolecular Engineering, University of Illinois at Urbana-Champaign, Urbana, IL 61801, United States; Energy Biosciences Institute, Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL 61801, United States. FAU - Chao, Ran AU - Chao R AD - Department of Chemical and Biomolecular Engineering, University of Illinois at Urbana-Champaign, Urbana, IL 61801, United States; Energy Biosciences Institute, Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL 61801, United States. FAU - Zhao, Huimin AU - Zhao H AD - Department of Chemical and Biomolecular Engineering, University of Illinois at Urbana-Champaign, Urbana, IL 61801, United States; Energy Biosciences Institute, Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL 61801, United States; Departments of Chemistry, Biochemistry, and Bioengineering, University of Illinois at Urbana-Champaign, Urbana, IL 61801, United States. Electronic address: zhao5@illinois.edu. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20140210 PL - Belgium TA - Metab Eng JT - Metabolic engineering JID - 9815657 RN - 0 (Adaptor Proteins, Signal Transducing) RN - 0 (Bacterial Proteins) RN - 0 (Butylene Glycols) RN - 0 (MTH1 protein, S cerevisiae) RN - 0 (Recombinant Proteins) RN - 0 (Saccharomyces cerevisiae Proteins) RN - 0 (Sweetening Agents) RN - 45427ZB5IJ (2,3-butylene glycol) RN - EC 1.1.- (Alcohol Oxidoreductases) RN - EC 1.1.1.4 (butanediol dehydrogenase) RN - EC 2.2.1.6 (Acetolactate Synthase) RN - EC 4.1.1.- (Carboxy-Lyases) RN - EC 4.1.1.5 (acetolactate decarboxylase) RN - IY9XDZ35W2 (Glucose) RN - X2RN3Q8DNE (Galactose) SB - IM MH - Acetolactate Synthase/biosynthesis/genetics MH - Adaptor Proteins, Signal Transducing/genetics/metabolism MH - Alcohol Oxidoreductases/biosynthesis/genetics MH - Bacillus subtilis/enzymology/genetics MH - Bacterial Proteins/biosynthesis/genetics MH - Butylene Glycols/*metabolism MH - Carboxy-Lyases/biosynthesis/genetics MH - Directed Molecular Evolution/methods MH - Galactose/*metabolism/pharmacology MH - Glucose/*metabolism/pharmacology MH - Metabolic Engineering/*methods MH - Recombinant Proteins/biosynthesis/genetics MH - Saccharomyces cerevisiae/*genetics/*metabolism MH - Saccharomyces cerevisiae Proteins/genetics/metabolism MH - Sweetening Agents/metabolism/pharmacology OTO - NOTNLM OT - (2R,3R)-Butanediol OT - Glucose derepression OT - Metabolic engineering OT - Pyruvate decarboxylase OT - Sugar co-utilization EDAT- 2014/02/15 06:00 MHDA- 2014/12/17 06:00 CRDT- 2014/02/15 06:00 PHST- 2013/06/25 00:00 [received] PHST- 2014/01/21 00:00 [revised] PHST- 2014/02/03 00:00 [accepted] PHST- 2014/02/15 06:00 [entrez] PHST- 2014/02/15 06:00 [pubmed] PHST- 2014/12/17 06:00 [medline] AID - S1096-7176(14)00009-3 [pii] AID - 10.1016/j.ymben.2014.02.003 [doi] PST - ppublish SO - Metab Eng. 2014 May;23:92-9. doi: 10.1016/j.ymben.2014.02.003. Epub 2014 Feb 10.